# Kenji Maeda

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kenji-maeda/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,807 |
| Field | SARS-CoV-2 and COVID-19 Research |
| h-index | 67 |
| i10-index | 240 |
| Last Known Institution | Kagoshima University |
| OpenAlex ID | https://openalex.org/A5055989025 |
| ORCID iD | https://orcid.org/0000-0002-9424-1491 |
| Works | 569 |

## Researcher papers

- [The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor Biosynthesis](https://scholariq.org/papers/the-cloning-of-pig-a-a-component-in-the-early-step-of-gpi-anchor-biosynthesis/)
- [beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.](https://scholariq.org/papers/beta-2-microglobulin-modified-with-advanced-glycation-end-products-is-a-major/)
- [Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice](https://scholariq.org/papers/atypical-antipsychotics-suppress-production-of-proinflammatory-cytokines-and-up/)

## Researcher topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Researcher university

- [Kagoshima University](https://scholariq.org/institutions/kagoshima-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.